-
This BioPharma Could Be First To Market With Its Celiac Therapy – Phase 3 Clinical Trials To Commence In 2024
Monday, January 22, 2024 - 10:56am | 184Read More...James Sapirstein, Chairman, President & CEO of First Wave BioPharma, Inc. (NASDAQ: FWBI) was recently a guest on Benzinga’s All-Access. First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for...
